Researchers summarize key insights from the world’s first comprehensive investigation into how a pandemic started.
Morning Overview on MSN
New nasal vaccine shields lungs for months from viruses, bacteria, and allergens
Stanford Medicine researchers have developed an experimental nasal vaccine that shielded mouse lungs for at least three months against a striking range of respiratory threats, from SARS-CoV-2 and ...
Lower Sugar Intake in Infancy Linked to Fewer Adult Heart Attacks: StudyLimiting sugar intake from pregnancy through the first two years of life ...
The EXPANDIA project demonstrates how cross-sector partnerships and RT-LAMP diagnostics can expand testing capacity in low-resource regions. The collaboration enabled cost-effective, saliva-based ...
A version of this Priestley Medal address will be presented at the American Chemical Society Spring 2026 meeting ...
Young infants hospitalized with respiratory syncytial virus (RSV) often become much sicker than those infected with ...
New findings published in the journal Cell about the Andes virus, a hantavirus endemic to the southwestern U.S. and other ...
Hantaviruses, transmitted from rodents to people, have a death rate approaching 40%. They're found around the world, and because there are no approved vaccines or treatments, they're among the ...
COVID-19 vaccinations were shown to reduce virus-related hospitalizations and severe disease-associated outcomes in immunocompetent adults. The findings from a recently published JAMA Network Open ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results